A New Surgical Method for Treating Tandem Carotid Lesions: Gao's Triple Eversion Carotid Endarterectomy

What this Trial Is About

Researchers are evaluating a new surgical method called Gao's triple eversion carotid endarterectomy (GTE-CEA) for treating tandem carotid lesions (TCLs), which involve severe narrowing or blockage in multiple areas of the carotid artery. This innovative procedure aims to address limitations of conventional carotid endarterectomy, which cannot effectively treat all types of TCLs. The study involves a retrospective review of patients who underwent GTE-CEA performed by the same vascular surgeons since September 17, 2021. The GTE-CEA procedure involves exposing the carotid arteries and carefully removing the plaque through a series of eversion steps. Surgeons raise blood pressure and use heparin during the operation to manage blood flow and prevent clots. The arteries are blocked and cut in specific locations to allow plaque removal from the internal and external carotid arteries as well as the common carotid artery. The plaque and debris are thoroughly cleaned using heparin irrigation before completing the procedure. Participants in this study had their medical charts reviewed to assess outcomes and safety, focusing on treatment-related adverse events over an average of three years. Patients underwent digital subtraction angiography or computed tomography angiography before surgery to confirm the severity of carotid artery stenosis. Researchers will monitor adverse events and long-term safety to evaluate the procedure. The study excludes patients who do not meet diagnostic criteria or have less severe stenosis or other artery blockages.

Gao's Triple Eversion Carotid Endarterectomy